Arun J Sanyal, MD, FAASLD

Biography

Arun J. Sanyal, M.D., is a Professor of Medicine, Physiology, and Molecular Pathology in the Division of Gastroenterology at Virginia Commonwealth University (VCU) Medical Center in Richmond, Virginia. At VCU, he is currently the Director of the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health. He is ranked in the top 0.1% of all biomedical scientists by Stanford University rankings and has the second highest lifetime impact of all scientists worldwide for liver disease. Dr. Sanyal serves as Chairman of the NIH NASH Clinical Research Network, the NIMBLE consortium, and the Liver Forum for NASH and fibrosis. His research interests include all aspects of NAFLD and NASH as well as complications of end-stage liver disease. He chaired the hepatobiliary pathophysiology study section of the NIH and was a founding member of the Hepatology committee of the American Board of Internal Medicine. He has also served as Secretary as well as President of the American Association for the Study of Liver Diseases. Dr. Sanyal has authored more than 500 articles in the highest tier journals such as the New England Journal of Medicine, Lancet and Nature Medicine. He has an H-index of 159 and his work was cited almost 18000 times in 2023 alone. He has been continuously funded by the NIH since 1995 and is the principal investigator of four active NIH grants. He has pioneered the development of diagnostics and therapeutics for end stage liver disease and fatty liver disease and currently leads multiple global trials for this condition. He is the recipient of the Distinguished Mentorship Award from the American Gastroenterological Association and the Distinguished Scientific Achievement Award from the American Liver Foundation in 2017 and the Distinguished Achievement Award from the AASLD in 2018.